ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 10 of 49
УЖМБС 2019, 4(4): 64–71
Clinical Medicine

Parameters of Carbohydrate Metabolism and Expression of Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease and Hypertensive Depending on Lipid Parameters

Babak O. Ya., Bashkirova A. D.

Non-alcoholic fatty liver disease is the most common liver disease in the world, its prevalence is 25%, but it is even more widespread in different population groups and regions. The main causes of death among patients with non-alcoholic fatty liver disease are cardiovascular diseases. The common triggers of non-alcoholic fatty liver disease and hypertension are metabolic disorders which confirm the complex pathological links between these two nosologies. The purpose of the study was to examine the concentration of endothelial lipase, as the leading regulator of HDL concentration, in groups distributed by HDL levels, necessary for understanding the pathogenetic ration in patients with non-alcoholic fatty liver disease and hypertension. Material and methods. 50 patients with non-alcoholic fatty liver disease on the background of GB were examined. Patients were divided into groups according to indicators of HDL levels. All patients underwent general clinical studies, as well as the determination of serum endothelial lipase levels and the determination of the degree of steatosis using the non-alcoholic fatty liver disease liver fat score. Results and discussion. In patients with non-alcoholic fatty liver disease on the background of hypertension, HDL concentration depended on the available insulin resistance and was associated with alcohol consumption. Analysis of the lipid profile showed a significant (р < 0.05) difference between all groups in terms of HDL. The concentration of total cholesterol was not significantly different in groups. At the same time, the level of triglycerides and LDL in patients with high HDL levels was lower. It is interesting that the highest level of endothelial lipase is also fixed in this group. The severity of liver steatosis in terms of transaminase levels and steatosis index was significantly (р < 0.05) higher in individuals with low HDL levels. The highest insulin resistance was observed in individuals with low levels of HDL compared with those who have a protective concentration of them. Levels of LDL in patients with non-alcoholic fatty liver disease on the background of hypertension have a direct proportionality with total cholesterol concentration, body mass index and abdominal fat distribution and are associated with increased blood pressure. A regression analysis showed a reliable (p <0.05) positive correlation of the level of endothelial lipase with the concentration of total cholesterol and negative with the concentration of LDL. The study of dependences of the concentration of endothelial lipase with lipidogram indices revealed a positive relationship only with the level of total cholesterol and a negative one with the level of LDL. Conclusion. Thus, the concentration of endothelial lipase did not show a direct relationship with the level of HDL in the plasma, which highlights its additional role in LDL metabolism in conditions of liver steatosis against the background of insulin resistance.

Keywords: non-alcoholic fatty liver disease, hypertension, lipids, endothelial lipase, insulin resistance

Full text: PDF (Rus) 241K

  1. Alkhouri N, Berk M, Yerian L, Lopez R, Chung YM, Zhang R, et al. OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease. Dig Dis Sci. 2014 Jul; 59(7):1 617-24.
  2. Barritt AS 4th, Gitlin N, Klein S, Lok AS, Loomba R, Malahias L, et al. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Contemp Clin Trials. 2017; 61: 33-8.
  3. DeFilippis AP, Blaha MJ, Martin SS, Reed RM, Jones SR, et al. Atherosclerosis. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2013 Apr; 227(2): 429-36.
  4. DiMarco DM, Fernandez ML. The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs. Biology. 2015; 4(3): 494–511.
  5. Du T, Sun X, Yu X. Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease. Lipids in Health and Disease. 2017; 16: 229.
  6. Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017 May; 65(5): 1557-65.
  7. European Association for the Study of the Liver et al. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Obesity facts. 2016; 9(2): 65-90.
  8. Ismail MH. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic. Am J Med Sci. 2011 Jun; 341(6): 485-92.
  9. Jiang ZG, Mukamal K, Tapper E, Robson SC, Tsugawa Y. Low LDL-C and High HDL-C Levels Are Associated with Elevated Serum Transaminases amongst Adults in the United States: A Cross-sectional Study. PLoS ONE. 2014; 9(1): e85366.
  10. Kilic H, Atalar E, Lay I, Yazihan N, Buyukcam F, Saygisunar U, et al. High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: a study in a land of low high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 2014 Jun; 74(4): 278-84.
  11. Lee YJ, Shim JY, Moon BS, Shin YH, Jung DH, et al. The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig Dis Sci. 2012; 57: 196-203.
  12. Liu H, Lu H-Y. Nonalcoholic fatty liver disease and cardiovascular disease. World J Gastroenterol. 2014; 20(26): 8407-15.
  13. Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, et al. Non-alcoholic fatty liver disease and vascular function – a cross-sectional analysis in the Framingham Heart Study. Arteriosclerosis, thrombosis, and vascular biology. 2015; 35(5): 1284-91.
  14. Madan SA, John F, Pyrsopoulos N, Pitchumoni CS. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: meta-analysis. Eur J Gastroenterol Hepatol. 2015; 27(11): 1237-48.
  15. Potočnjak I, Trbušić M, Terešak SD, Radulović B, Pregartner G, Berghold A, et al. Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients. Scientific Reports. 2017; 7: 1165.
  16. Puri P, Fuchs M. Population Management of Nonalcoholic Fatty Liver Disease. Fed Pract. 2019 Feb; 36(2):7 2-82.
  17. Stępień M, Wlazeł RN, Paradowski M, Banach M, Rysz M, Misztal M, Rysz J. Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study. Arch Med Sci. 2012 Jul 4; 8(3): 431-6.
  18. Tani M, Horvath KV, Lamarche B, Couture P, Burnett JR, Schaefer EJ, Asztalos BF. High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency. Atherosclerosis. 2016 Oct; 253: 7-14.
  19. Trojak A, Waluś-Miarka M, WoŸniakiewicz E, Małecki MT, Idzior-Waluś B. Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2013; 19: 1167-72.
  20. Yki-Järvinen H. Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance. Nutrients. 2015; 7(11): 9127-38.
  21. Yu JE, Han SY, Wolfson B, Zhou Q. The role of endothelial lipase in lipid metabolism, inflammation, and cancer. Histol Histopathol. 2018 Jan; 33(1): 1-10.